Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system

scientific article published on 22 July 2015

Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJDRC-2015-000093
P932PMC publication ID4513350
P698PubMed publication ID26217493
P5875ResearchGate publication ID280535685

P50authorMichael W KattanQ60653077
P2093author name stringBrian J Wells
Alex Milinovich
Jonathan Bouchard
Changhong Yu
Robert S Zimmerman
Brian Sakurada
Sheldon X Kong
Wayne Weng
Kevin M Pantalone
Todd M Hobbs
Janine M Bauman
P2860cites workEffect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular CausesQ22250883
Standards of medical care in diabetes--2014Q28304435
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialQ29619886
Prevalence of diabetic retinopathy in the United States, 2005-2008.Q34154127
Standards of medical care in diabetes--2011.Q34425055
Centers for Disease Control and Prevention. State indicator report on Physical Activity, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014Q34471904
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.Q34628009
Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association studyQ35751198
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control studyQ36001145
The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.Q37022665
Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilizationQ37260160
Nephropathy in diabetesQ44705106
Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.Q46046433
Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetesQ46401219
Achievement of goals in U.S. diabetes care, 1999-2010.Q51045064
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysisQ63966646
Changes in diabetes-related complications in the United States, 1990-2010Q64125961
Integrated delivery systems: the cure for fragmentationQ82582723
P433issue1
P921main subjectcomorbidityQ1414874
type 2 diabetesQ3025883
P304page(s)e000093
P577publication date2015-07-22
P1433published inBMJ open diabetes research & careQ27725999
P1476titleClinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system
P478volume3

Reverse relations

cites work (P2860)
Q38796894Biomechanisms of Comorbidity: Reviewing Integrative Analyses of Multi-omics Datasets and Electronic Health Records
Q64105044Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans
Q57164680Continuous Glucose Monitoring: Current Use in Diabetes Management and Possible Future Applications
Q47636753Correlation of Electrophotonic Imaging Parameters With Fasting Blood Sugar in Normal, Prediabetic, and Diabetic Study Participants
Q57294147Diabetes and the direct secondary use of electronic health records: Using routinely collected and stored data to drive research and understanding
Q49833824Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Q38994655Dynamics of diabetes and obesity: Epidemiological perspective
Q64938193Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies.
Q92892527Eugenia jambolana extract reduces the systemic exposure of Sitagliptin and improves conditions associated with diabetes: A pharmacokinetic and a pharmacodynamic herb-drug interaction study
Q55646317Evaluation of a Diabetes Self-Management Program: Claims Analysis on Comorbid Illnesses, Health Care Utilization, and Cost.
Q64068724Exploring the relationship between coronary heart disease and type 2 diabetes: a cross-sectional study of secondary prevention among diabetes patients
Q93016948From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research
Q28080114Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure
Q92307608Indicators of Quality of Clinical Care for Type 2 Diabetes Patients in Primary Health Care Centers in Qatar: A Retrospective Analysis
Q51213030Levels of heavy metals and their binding protein metallothionein in type 2 diabetics with kidney disease.
Q38865936Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss.
Q38912660Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort study
Q36106099Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data
Q64075400Predictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia
Q47329557Prevalence and co-prevalence of comorbidities in Belgian patients with type 2 diabetes mellitus: a transversal, descriptive study
Q91583309Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy
Q91759548SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice
Q55035609The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal.
Q91787194The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States
Q93128624The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes
Q47103092Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis.
Q90345914Transplantation of IL-10-Overexpressing Bone Marrow-Derived Mesenchymal Stem Cells Ameliorates Diabetic-Induced Impaired Fracture Healing in Mice
Q47150840Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening
Q64105782Validation of Two Automatic Blood Pressure Monitors With the Ability to Transfer Data via Bluetooth
Q90402294[Primary Prevention of Acute Stroke]